Technical Analysis for MGNX - MacroGenics, Inc.

Grade Last Price % Change Price Change
C 3.87 5.74% 0.21
MGNX closed up 5.74 percent on Friday, November 1, 2024, on 81 percent of normal volume.
Earnings due: Nov 4
*** please verify all earnings dates ***
5 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Up 3 Days in a Row Strength 0.00%
Bullish Engulfing Bullish 5.74%
Crossed Above 50 DMA Bullish 5.74%
Pocket Pivot Bullish Swing Setup 5.74%
Oversold Stochastic Weakness 5.74%
50 DMA Resistance Bearish 13.82%
MACD Bearish Centerline Cross Bearish 13.82%
Stochastic Buy Signal Bullish 13.82%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 19 hours ago
Up 1 ATR about 19 hours ago
60 Minute Opening Range Breakout about 20 hours ago
Up 5% about 20 hours ago
Rose Above 20 DMA about 21 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

MacroGenics, Inc. Description

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules. The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines. The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immunology Immune System Autoimmune Disease Antibodies Treatment Of Cancer Monoclonal Antibodies Monoclonal Antibody Antibody Novel Cancer

Is MGNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 21.88
52 Week Low 2.9511
Average Volume 602,231
200-Day Moving Average 8.75
50-Day Moving Average 3.55
20-Day Moving Average 3.79
10-Day Moving Average 3.66
Average True Range 0.25
RSI (14) 55.95
ADX 16.8
+DI 25.10
-DI 23.67
Chandelier Exit (Long, 3 ATRs) 3.62
Chandelier Exit (Short, 3 ATRs) 3.96
Upper Bollinger Bands 4.30
Lower Bollinger Band 3.27
Percent B (%b) 0.58
BandWidth 27.10
MACD Line 0.01
MACD Signal Line 0.04
MACD Histogram -0.0307
Fundamentals Value
Market Cap 240.05 Million
Num Shares 62 Million
EPS 0.81
Price-to-Earnings (P/E) Ratio 4.78
Price-to-Sales 9.37
Price-to-Book 5.54
PEG Ratio 0.01
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.32
Resistance 3 (R3) 4.30 4.12 4.25
Resistance 2 (R2) 4.12 4.01 4.14 4.22
Resistance 1 (R1) 4.00 3.94 4.06 4.02 4.19
Pivot Point 3.82 3.82 3.86 3.84 3.82
Support 1 (S1) 3.70 3.71 3.76 3.72 3.55
Support 2 (S2) 3.52 3.64 3.54 3.52
Support 3 (S3) 3.40 3.52 3.50
Support 4 (S4) 3.42